Research on infections caused by bacteria and how to fight them. Covers antibiotic resistance, biofilms, congenital syphilis, Lyme disease, and precise treatments.
A study published in eLife has linked infection with the bacterium Fusobacterium nucleatum to an increased risk of cardiovascular disease. The researchers found that individuals with high genetic risk scores for coronary heart disease were at elevated risk for cardiovascular events.
Scientists at University of Warwick and Politecnico di Milano developed a tool to regulate bacterial electric signals with light, opening new avenues for understanding antimicrobial resistance. This technology could help explain how some bacteria survive antibiotic exposure.
Researchers discovered that sensory cells in the spinal cord's central canal can detect bacteria in cerebrospinal fluid and trigger an inflammatory response to fight brain infections. These 'taste' receptors recognize bitter substances, such as those from Streptococcus pneumoniae, and increase cytokine production to combat pathogens.
Researchers found that two proteins help MRSA cells pump toxins into their environment. Targeting these proteins could disable MRSA and reduce its virulence.
Researchers have characterised the mutually beneficial relationship between Klebsiella pneumoniae and Acinetobacter baumannii, two pathogens responsible for severe infections. This relationship enables Klebsiella to survive in higher antibiotic concentrations, making it more deadly and resistant to treatment.
Researchers have developed a new diagnostic test called p-LFAs that can detect and quantify protein concentrations to identify bacterial and viral infections. The test is 1,000 times more sensitive than conventional tests, returning results in just 20 minutes.
A study by University of Liverpool researchers reveals how a unique subset of lung T regulatory cells provide resistance to bacteraemic pneumonia. These cells, known as TNFR2 expressing Tregs, play a critical role in maintaining and controlling frontline host immune responses when pneumococci infect the lungs. The findings have signifi...
Researchers investigated TB screening effectiveness in Germany and globally, finding mandatory programs may increase participation but don't deliver better results. Voluntary programs are considered more effective, ethically and legally justifiable.
A research team led by Professor Xiang David LI has developed a novel chemical tool called photo-ANA to investigate bacterial interactions with the host in real-time. This approach enables scientists to comprehensively profile host–bacteria protein interactions during infection, revealing known and newly discovered interactions.
A new microbiome therapeutic, SER-109, has been shown to improve the quality of life of patients with Clostridium difficile (C. diff) infections by reducing symptoms and restoring colonization resistance. The treatment was found to be associated with significant improvements in health-related quality of life scores as early as Week 1.
Researchers successfully treated a young man with recurrent non-gonococcal urethritis caused by Mycoplasma genitalium using chloramphenicol. The patient showed improvement after 14 days of treatment, despite initial failure with first and second-line antibiotics.
Researchers found that carriers of a specific hidden bacteria have a 14% chance of developing an antibiotic-resistant infection within 30 days of hospitalization. The study highlights the significant risk of infections from multidrug-resistant Gram-negative bacteria, particularly in patients undergoing 'dirty' surgery.
Research suggests that a new combination of drugs is needed to find an effective treatment for TB meningitis due to multidrug-resistant strains. The FDA-approved BPaL regimen is not effective in treating TB meningitis because bedaquiline and linezolid cannot penetrate the blood-brain barrier.
Researchers from UC San Diego and Yale University are exploring the therapeutic potential of
The study reveals that repeated mutations in the sarZ gene lead to increased severity of MRSA blood stream infections, and that surface protein ClfB plays a critical role in pathogenesis. The findings provide insights into the factors contributing to MRSA virulence and may help uncover new treatment approaches.
Researchers analyzed how immunological memory gets generated and maintained to understand its role in cancer and inflammatory diseases. They found that increased inflammation can actually reduce immunological memory, highlighting the need for regulation.
Researchers at Aston University have created the world's first computer reconstruction of a virus, including its complete native genome. This breakthrough could lead to the development of targeted treatments to kill bacteria that are dangerous to humans, reducing the threat of antibiotic resistance.
A study led by Robert Dickson found that the gut microbiome plays a crucial role in regulating body temperature, both in health and during sepsis. The researchers discovered that certain bacteria from the Firmicutes phylum were strongly associated with increased fever response.
A new study published in Evolution, Medicine, and Public Health found that proper hand hygiene in clinical work can reduce the spread of antibiotic-resistant bacteria. The researchers developed a mathematical model to predict how good or poor hygiene affects resistance evolution, and tested it against data from 691 long-term care facil...
A Phase 2 clinical trial found that a probiotic reduced S. aureus colonization by 96.8% in the stool and 65.4% in the nose. The probiotic Bacillus subtilis was administered orally, surviving passage through the stomach, and did not harm gut microbiota.
Researchers discovered that urinary tract infections can arise after sterile tubes are inserted into the urinary tract, even when no bacteria are detectable beforehand. This study suggests that screening patients for hidden reservoirs of dangerous bacteria could supplement infection-control efforts and help prevent deadly infections. B...
Researchers developed an injectable hydrogel that inhibits common bacteria and promotes tissue regrowth, treating infections around prosthetics. The gel has a porous structure, excellent injectability, and rapid self-healing properties.
Researchers at the University of Cincinnati found a link between latent tuberculosis infection and increased inflammation in monocytes, a type of white blood cell. This connection may contribute to a higher risk of cardiovascular disease in individuals with LTBI.
Half of online sellers fail to disclose law and disease risks associated with small turtles. Despite federal regulations, many US sellers circumvent public health guidelines when selling these pets.
Researchers discovered that enterococci, a type of antibiotic-resistant bacteria, can make C. difficile more potent and dangerous by producing amino acids. This understanding could help doctors identify patients at risk and develop new treatments for the deadly infection.
A North Carolina State University study found that mosquitoes harbor diverse bacterial communities, including those associated with human diseases. The research revealed greater bacterial diversity internally than externally, suggesting that mosquitoes may transfer pathogenic bacteria through physical contact or defecation.
Researchers at Princeton University have isolated a compound called cloacaenodin, which is a potent antibacterial peptide that can kill clinically relevant drug-resistant strains of Enterobacter. This discovery has significant implications for the treatment of bacterial infections and could lead to new antibiotic development.
Researchers found that fleas with early-phase infection are insufficient to drive epizootic outbreaks but can promote a low level of enzootic plague. Early-phase transmission may help maintain the enzootic state by reducing susceptible individuals in the population.
The December issue of CHEST journal features articles on COVID-19 lessons learned and future pandemic preparedness. The journal also explores various topics in chest medicine, including asthma, critical care, and sleep medicine.
A new study at the University of Tokyo has mapped the evolution and process of natural selection in Escherichia coli bacteria, creating fitness landscapes that help understand drug resistance and potential treatments. The researchers hope their results will be useful for predicting and controlling E. coli and other bacteria.
Researchers identified a strong association between beneficial bacteria and estrogen hormone therapy in postmenopausal women. The study found that estrogen may play a role in reducing susceptibility to recurrent UTIs by promoting the growth of good bacteria such as Lactobacilli in the bladder. Conversely, women with recurrent UTIs had ...
A global study reveals that antimicrobial resistance genes in bacteria are driven by various factors, including geographic regions and hosts. The research identifies key genes conferring resistance to critically important drugs, shedding light on the mechanisms of transmission and the need for collaborative interventions.
Researchers at Lund University discovered an antibody with potential to protect against Strep A infection and a rare form of binding that leads to effective immune response. The finding could explain why many Group A strep vaccines have failed.
A study found that genetic variants near ERAP2 and TICAM2 provided protection against Yersinia pestis, the bacterium responsible for the Black Death. These variants were also associated with improved detection and resistance to other pathogens, but at a cost: increased risk of autoimmune disorders like Crohn's disease.
A study published in the Journal of Dentistry found that patients with unexplained brain abscesses were three times more likely to have oral bacteria present. The researchers also discovered significantly higher counts of Streptococcus anginosus, a bacterium linked to dental abscesses and infections in internal organs.
Researchers found that a vaccine against the toxin produced by E. coli protects infant mice from intestinal damage, suggesting it could boost global efforts to combat childhood malnutrition. Vaccinating kids against E. coli diarrhea may prevent long-term effects like stunting and micronutrient deficiencies.
Researchers have uncovered a new mechanism of antibiotic resistance in Group A Streptococcus bacteria, making antibiotics ineffective and potentially leading to poor outcomes. The discovery highlights the complexity of understanding AMR and emphasizes the need for rapid diagnostic tools and therapeutics.
Researchers at the University Hospital Bonn have discovered a new function of CRISPR/Cas9 gene scissors, which produce small signal molecules that bind to proteins, activating an emergency response. This discovery opens up new possibilities for treating diseases using CRISPR technology.
Researchers at Karolinska Institutet have identified the most common bacteria found in severe oral infections, shedding new light on the association between oral health and systemic diseases. The study found that certain bacterial infections can spread to other parts of the body, highlighting the importance of understanding the role of...
A recent study found that superbugs in the environment rarely transmit to humans, contrary to previous fears. The researchers discovered high levels of antimicrobial-resistant bacteria in livestock, pets, and environmental samples, but surprisingly little overlap between hospital and environmental strains.
A new study by CHOP researchers found that antibiotic-resistant Enterococcus enhances C. difficile virulence by modulating the gut environment, increasing toxin production and nutrient supply. This interaction supports increased colonization and persistence of C. difficile in the gut.
A new study by Weill Cornell Medicine investigators finds that Enterococcus faecalis enhances its protective outer layer to resist natural immune defenses and antibiotics. The research suggests possible new ways to target these bacterial infections.
Researchers identify unique chemical signal allowing ancient TB bacteria to evade immune system and spread beyond lungs. The 'mobile factor', called EsxM, allows the bacteria to infect macrophages more easily, leading to bone infections in six people.
The risk of death from infective endocarditis (IE) among young US residents aged 15-44 years has doubled in the last two decades. IE cases among younger patients and those who inject drugs have increased, with mortality rates increasing by 50%.
Urban-living Indigenous children and young people in high-income countries are disproportionately affected by atopic dermatitis and bacterial skin infections, which can lead to serious complications. This systematic review highlights the need for co-designed research with Indigenous communities to address these health inequities.
Co-infection with gut parasites increases shedding of respiratory bugs like Bordetella bacterium, leading to higher probability of onward transmission. This study in rabbits has broad implications for human populations and suggests targeting treatment of helminths could be an effective way to reduce disease outbreaks.
Research suggests that antibiotics used in ovarian cancer treatment can accelerate cancer progression and lower survival rates. Reintroducing healthy gut bacteria may slow down cancer growth and restore sensitivity to chemotherapy.
A new AI technology has been developed to automatically diagnose lung diseases such as tuberculosis and pneumonia, freeing up radiographers and reducing waiting times for test results. The system, which uses X-ray imaging and deep learning algorithms, achieved a 98% accuracy rate during extensive testing.
A new treatment option for multi-resistant bacteria has been identified by a UNIGE team, which uses the drug edoxudine to weaken the defence mechanisms of Klebsiella pneumoniae, making it easier to eliminate. This approach could be a game-changer in the fight against antibiotic resistance.
A new study by Ochsner pharmacist Kevin Lin suggests that oral cephalosporins are as safe and effective as fluoroquinolones for treating acute kidney infections. The study's findings support the use of narrower-spectrum antibiotics to reduce antimicrobial resistance, a growing concern in healthcare.
The study found that protein kinase CK2 plays a key role in regulating CD8+ T cell activation, metabolic reprogramming and differentiation during infection by the intracellular pathogen Listeria monocytogenes. In mouse models, deletion of the CK2α catalytic subunit impaired CD8+ T cell function.
A new study found that COVID-19 infection directly interferes with the healthy balance of microbes in the gut, further endangering patients. The research revealed that antibiotic-resistant species can escape into the bloodstream, putting patients at greater risk for life-threatening secondary infections.
Researchers at Osaka University have discovered the spatial characteristics of an efflux pump that helps bacteria resist antibiotics. By analyzing a specific inhibitor's binding site, they found bulky mutations can prevent the inhibitor from working, offering hope for developing new countermeasures to combat antibiotic resistance.
Researchers have developed a way to load potent antibiotics like Polymyxin B into red blood cells, allowing them to selectively target and kill drug-resistant bacteria. This technology could help address the ongoing antibiotic resistance crisis and deliver drugs more quickly and directly to specific sites in the body.
Researchers from Johannes Gutenberg University Mainz developed ceria nanoparticles to silence bacteria by modifying signaling molecules, preventing biofilm formation. This approach mimics nature's defense system and has potential for creating antibacterial surfaces without resistance.
New research reveals a relationship between virus concentration and organic carbon in wastewater treatment plant effluents. The study found that viruses can affect the concentration of organic carbon, leading to potential negative impacts on aquatic ecosystems nearby.
A randomized clinical trial found that applying topical antibiotics to the upper digestive tract can improve survival rates in mechanically ventilated intensive care patients. The study, published in JAMA, also showed a significant reduction in new hospital-acquired infections.
A new drug combination of cefepime and enmetazobactam has been found to be more effective in treating complicated urinary tract infections and acute pyelonephritis than a standard treatment. The study showed that the new combination was successful in treating 79% of patients, compared to 58.9% for the conventional treatment.
Researchers analyzed S. lugdunensis isolates from pediatric patients and found that skin infections were a common source (68%), while CNS infections linked to VP shunts were also significant. Flucloxacillin was identified as effective against the bacterium.
Researchers developed a small peptide that can directly kill bacteria and trigger plant defense tactics to prevent diseases like almond leaf scorch. The treatment significantly reduces pathogen population and disease symptoms, making it a promising approach for sustainable crop protection.